Applied DNA Reports Fiscal Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. FMC
8. AA
9. RKLB
10. VRNS

Go back to Applied DNA Reports Fiscal Third Quarter 2020 Financial Results

Applied DNA Sciences (APDN) Misses Q3 EPS by 5c

August 6, 2020 5:28 PM EDT

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.72), $0.05 worse than the analyst estimate of ($0.67).

We continued during the quarter to position the Company to serve the unmet and evolving needs for COVID-19 testing solutions and vaccine development, said Dr. James A. Hayward, president and CEO of Applied DNA Sciences. Upon the receipt of FDA Emergency Use Authorization (EUA) for our Linea COVID-19 diagnostic assay kit (for use with nasopharyngeal (NP) swab and anterior nasal swab (ANS) sample collections), we put into place the foundation of our COVID-19 diagnostics business: we established the requisite supply... More